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Abstract
Background: Superficial leiomyosarcoma is an exceedingly uncommon malignant tumor which
could be located either to cutaneous or subcutaneous tissues. Increased mass size and depth,
advanced tumor staging and inadequate surgical excision are the main prognostic factors for poor
result.
Case presentation: We report a rare case of a 71-year-old man with an extensive exophytic
lesion (12 × 10 cm) in the anterior-medial side of the proximal right tibia. The lesion was painless
and consistently neglected by the patient until a skin trauma caused ulceration of the affected area.
Magnetic Resonance Imaging revealed a soft-tissue mass which was well defined from the
surrounding bone and muscles. As initial biopsy in another hospital hadn't clarified the true nature
of the lesion, new samples were taken and the diagnosis of leiomyosarcoma was established.
Laboratory examination showed no distant metastasis and wide excision of the neoplasm was
decided. After tumor resection, the remaining soft tissue and skin defect was covered with a
gastrocnemius myocutaneous flap. The postoperative period was uneventful and wound healing
was followed by local radiotherapy and systemic chemotherapy. At 3 years follow up, no
recurrence or metastasis was identified and the patient was able to walk and stand without
impairment of his ambulatory status.
Conclusion: Proper surgical management of soft tissue leiomyosarcoma continues to remain the
cornerstone of treatment efficacy and the most important prognostic factor for patients' survival.
Reconstruction of the remaining soft tissue defect should be always performed at the same
operative time when removal of giant size tumors leaves an uncovered cavity with an inadequate
sleeve of muscular and skin tissues.
Background
Superficial Leiomyosarcoma (LMS) is a quite uncommon
tumor which is mainly developed in the proximal portion
of the lower limbs [1-3]. The lesion can be appeared as a
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single nodular mass or multiple swelling tumours [2,4].
Although it may occur in any age, superficial LMS is more
prevalent between the fifth and seventh decade of life.
Furthermore, a male predominance with a male-to-female
ratio of 2:1 was also described [1,2]. The tumor could be
located either cutaneously or subcutaneously. In the first
case, it is arisen from the limb extensor surfaces where a
greater density of hair structures (arrectores pilorum mus-
cles) exists [1,2,5]. It is frequently quite small-less 2 cm-
causing local changes like skin discoloration, umblication
and ulceration [1,2].
Subcutaneous soft tissue Leiomyosarcomas (LMSs) are
apparently larger and vascular in their origin, grow faster
and they may produce similar changes in the skin. Their
incidence is even rarer accounting for 2.3 – 5.3% of all
malignant soft tissue tumors [1,5] and 4 – 6,5% of all soft
tissue sarcomas [6,7]. As clinical signs are not strongly
suggestive of malignancy and vary from person to person,
the definitive diagnosis may be delayed until the later
stage of the disease [2]. Wide excision constitutes the cur-
rent treatment of choice [1,2,5,8-15] while radiotherapy
(RTP) and chemotherapy (CTP) may be considered in
high grade lesions [1,2,10,12-15].
We report a rare case of a giant subcutaneous LMS of the
proximal tibia. Wide excision of the tumour in combina-
tion with local RTP and systemic CTP led to good func-
tional outcome and no recurrence until the latest follow
up (3 yrs postoperatively).
Case presentation
A 71-year-old man, without medical history, referred to
Tumor Outpatient Clinic of the Hospital due to an exten-
sive exophytic mass of the anterior-medial side of the right
proximal tibia. The lesion was appeared ulcerated and
bloody with irregular areas of necrosis and haemorrhage
and its size was 12 × 10 cm with collar of around 10 cm.
(Figure 1). The patient reported that the mass was com-
pletely asymptomatic and its growth was slow. He wasn't
worried about its nature until an innocuous trauma
caused ulceration at tumor site 2 weeks ago. Plane X-Rays
showed a radiolucent lesion adjacent to the anterior-
medial side of the proximal tibia without cortical disrup-
tion or continuity with the bone (Figure 2). Magnetic Res-
onance Imaging (MRI) confirmed the suprafascial
character and extension of the lesion and revealed no clear
relationship with the surrounding muscles and bone (Fig-
ure 3). The previously performed open biopsy couldn't
clarify the true nature of the lesion as the described diag-
nosis was "unspecified soft tissue sarcoma". According to
the above findings and after patient's referral, new sam-
ples were received and histologic examination showed a
soft tissue leiomyosarcoma. Subsequent Computed Tom-
ography (CT) scans of chest and abdomen and total bone
scan excluded the presence of systemic lesions or metasta-
sis and the patient was scheduled to undergo surgical
resection of the lesion with additional removal of a sleeve
of surrounding tissues.
Under general anaesthesia and tourniquet application, en
block wide excision of the mass was performed. As the
Anteroposterior (A) and Lateral (B) X-Ray view of the right  knee Figure 2
Anteroposterior (A) and Lateral (B) X-Ray view of the right 
knee. A soft tissue mass in the anterior-medial side of the 
proximal tibia with no evident continuity with the bone or 
cortical invasion was apparent.
Macroscopic appearance of the exophytic mass in the ante- rior-medial side of the right leg Figure 1
Macroscopic appearance of the exophytic mass in the ante-
rior-medial side of the right leg. The mass showed nodular 
growth pattern and the cut surfaces were ulcerated and 
bloody with irregular areas of necrosis.International Seminars in Surgical Oncology 2008, 5:11 http://www.issoonline.com/content/5/1/11
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tumor was very close to the bone, a portion of the ante-
rior-medial cortex of the proximal metaphysis of the tibia
was also removed to facilitate at least 2 cm resection mar-
gins circumferentially (Figure 4). After tumor excision, a
large skin and soft tissue defect was remained and trans-
plantation of gastrocnemius myocutaneous flap was
deemed necessary for covering the defect (Figure 5). At the
end of the procedure, the tourniquet was released and the
vascular integrity of the flap and limb was evaluated.
At histological analysis, multiple elongated cells of mes-
enchymal origin surrounded by myofibrils and many
polygonal epithelioid cells with evident pleiomorphism
and elevated mitotic index were found. The surgical mar-
gins were free of disease and some necrotic areas were rec-
ognised as well. The positive immunohistochemical
staining for smooth muscular actin, vimentin and caldes-
mon led to diagnosis of grade III LMS according to the
grading scale modified from Broders et al. and Angervall
et al. [16,17] (Figure 6).
The postoperative course was uneventful and no local or
systemic complications were encountered. Due to the
weakening of the proximal tibia from the excision of the
anterior-medial cortex, partial weight bearing for 6 weeks
was advised. After wound healing the patient was submit-
ted to the Oncology Department for local RTP and sys-
temic CTP.
At the latest follow up visit (3 years) clinical and labora-
tory examination (X-Rays, MRI, Bone Scan) didn't reveal
any signs of tumor recurrence or metastasis. The patient
could stand and walk without any restriction and he was
able to perform his usual daily activities.
Discussion
The distinction between cutaneous and subcutaneous
LMS is of primary importance for prognostic reasons
[2,8,10]. Although the cutaneous LMSs are associated
with local recurrence in about 30–50% of cases only a low
incidence of 0–10% of metastasis has been described
[1,2,15,18]. On the other hand, subcutaneous LMSs may
develop local recurrence in about 40–60% of patients and
distant metastasis in 20 to 60% of patients
[1,2,5,8,10,12,15]. As a result, the mortality may be raised
up to 30–40% [2,18]. Despite the fact that tumor location
and depth affect the recurrence rate and metastatic risk,
the mitotic activity seems not to have a similar effect
[1,2,8].
In the current patient, the size of the tumor (12 × 10 cm)
was higher than the previously reported cases. Specifi-
cally, the mean size reported in literature for superficial
LMSs is about 5 cm, with a wide range from 0.5 to 19 cm
[2,4,8,19]. Some authors described cases of LMSs with
larger size (up to 35 cm), but in their series they didn't dis-
tinguish the superficial soft tissue LMSs from non-visceral
deep LMSs [15,20]. Large tumors (>5 cm) are considered
Axial (A) and Coronal (B) MRI T1-weighted image of the right proximal tibia Figure 3
Axial (A) and Coronal (B) MRI T1-weighted image of the right proximal tibia. A large homogeneous mass which was invaded 
the adjacent soft tissue and extended along the medial surface of cutaneous plane was visible. No signs of bone tissue infiltra-
tion, or abnormal intensity in muscle tissues could be seen.International Seminars in Surgical Oncology 2008, 5:11 http://www.issoonline.com/content/5/1/11
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to have worst prognosis in terms of recurrence and metas-
tasis [1,8,12-15]. In a multivariate analysis of 267 patients
with leiomyosarcoma, Miyajima et al. found that tumour
size and advanced staging were the only factors that were
correlated independently with decreased survival [20].
Wide excision of the lesion is of outmost importance as it
is strongly correlated with disease-free survival
[1,2,8,10,12-15]. Massi et al. in a retrospective study of 62
patients with extremity soft tissue leiomyosarcoma
reported that seven out of the nine patients who had
developed one or more local recurrences had been surgi-
cally treated with either marginal or intralesional excision
[13]. Similarly, Svarvar et al. in a large study of 225
patients with leiomyosarcoma which was based on Scan-
dinavian Sarcoma Group Register showed that the inade-
quate local treatment was the main risk factor for local
recurrence [15].
Many authors have been supported the application of
postoperative RTP and CTP in high grade LMSs
[1,2,10,12-15]. However, the role of adjuvant therapy in
LMSs is still controversial as no sufficient statistical evi-
dence exists regarding their efficacy. The above treatment
modalities may have a higher impact on local and sys-
temic tumor respond when adequate excision of large and
high grade lesions could not be achieved [13-15].
Conclusion
Even though delayed diagnosis and giant size of soft tissue
leioymyosarcomas may adversely affect the final result,
successful recovery could be anticipated. Special focus
should be given to careful and meticulous wide excision
of the mass as the role of chemotherapy and radiotherapy
is still blur and unknown.
Macroscopical post-operative aspect of patient's leg Figure 5
Macroscopical post-operative aspect of patient's leg. Ade-
quate coverage of defects of the tibia was obtained with the 
gastrocnemius myocutaneous flap.
Post-operative Anteroposterior X-Ray view of the proximal  tibia Figure 4
Post-operative Anteroposterior X-Ray view of the proximal 
tibia. Bone resection was decided for the achievement of 
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Microscopic features at high magnification included (A) the  high number of pleomorphic cells with frequent mitosis and  (B) the focally fused cells with central nucleus (hematoxylin  and eosin, × 400) Figure 6
Microscopic features at high magnification included (A) the 
high number of pleomorphic cells with frequent mitosis and 
(B) the focally fused cells with central nucleus (hematoxylin 
and eosin, × 400). (C) Immunohistochemical staining Caldes-
mon. According to this technique a diagnosis of grade III LMS 
was made (caldesmon, × 20).